Antibiotic Prescription Relevance Indicators: Calculation From Electronic Health Records
ARIPPA
Automatisation du Recueil d'Indicateurs de Pertinence de Prescription d'Antibiotiques : Développement, Validation et efficacité d'un Outil Utilisant Les systèmes d'Information d'un Groupement Hospitalier de Territoire
1 other identifier
observational
2,115
1 country
8
Brief Summary
This research focuses on the development and validation of indicators on the relevance of antibiotic prescriptions. The investigators want to propose transferable tools to other healthcare institutions to allow automated construction of quality indicators as part of a structured approach to improve future practices. The main objective of the study is to develop indicators on the appropriateness of antibiotic prescriptions and on surgical prophylaxis automated from the hospital information system and to assess their criterion validity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2021
CompletedFirst Submitted
Initial submission to the registry
May 24, 2022
CompletedFirst Posted
Study publicly available on registry
June 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJune 15, 2022
April 1, 2022
4 years
May 24, 2022
June 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity of the automatic tool to identify inappropriate antibiotic prescriptions compared to classical practices audits (gold standard).
Indicator "inappropriate treatment lasting more than 7 days": antibiotic treatment initiated or continued more than 7 days in clinical situations (urinary and respiratory infections) where a shorter treatment is recommended Indicator "surgical antibiotic prophylaxis lasting more than 24 hours": antibiotic given for a more than 24 hours for a surgical procedure requiring antibiotic prophylaxis The gold standard is the judgement of prescription appropriateness by infectious diseases experts. The gold standard will be measured independently from the automatic tool. Data will be manually extracted from patient electronic health record and assessed, independently, by two infectious diseases specialists to identify inappropriate prescriptions. In case of disagreement, an expert committee will be convened.
Between January 2021 and December 2024
Secondary Outcomes (8)
Metrological performances of each indicator
Between January 2021 and December 2023
Number of responses done by the system
Between December 2022 and December 2024
Number of response with justification of the prescription
Between December 2022 and December 2024
Number of alerts without responses from the prescriber
Between December 2022 and December 2024
Evaluate the score with scale MAUQ_E
Between June 2023 and December 2024
- +3 more secondary outcomes
Study Arms (1)
Patient who received antibiotic prophylaxis
Patient who received antibiotic prophylaxis to assess appropriateness and consumption of treatment.
Interventions
The system will identify inappropriate antibiotic prescriptions.
Eligibility Criteria
Patients whose medical and administrative data are available in an electronic format in the hospital information system, Adult patients aged over 18.
You may qualify if:
- Patients whose medical and administrative data are available in an electronic format in the hospital information system
- Adult patients aged over 18;
- Patients hospitalized at the Bordeaux University Hospital or one of the hospital of the territorial organization ;
- Patients hospitalized between 01/01/2022 and 31/12/2024 ;
- Indicator 1: "antibiotic treatments of more than 7 days without justifications"
- Patients with of a hospitalization of more than 24 hours;
- Patients with urinary or respiratory infections on admission or during the hospitalization (including sepsis related to urinary or respiratory infection);
- Patients with a prescription for at least one antibiotic, initiated on admission or during the hospitalization, for more than 7 days including the hospital prescription AND the discharge prescription
- Indicator 2: "surgical antibiotic prophylaxis lasting more than 24 hours"
- Patients with surgery requiring an antibiotic prophylaxis
- Patients having received antibiotic prophylaxis
You may not qualify if:
- Patients not hospitalized at the Bordeaux University Hospital or one of the hospital of the territorial organization.
- Patients whose medical and administrative data are not available in an electronic format in the hospital information system;
- Patients who have refused the secondary use of their data for research purpose
- Indicator 1: "Indicator of antibiotic treatments of more than 7 days without justifications"
- Patients with another concomitant infectious pathology
- Patient with pulmonary or urinary tuberculosis
- Indicator 2: "surgical antibiotic prophylaxis lasting more than 24 hours"
- Patients without any surgery or with surgery for which antibiotic prophylaxis is not required
- Patients without antibiotic prophylaxis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Bordeauxlead
- University of Bordeauxcollaborator
Study Sites (8)
Arcachon Hospital
Arcachon, 33120, France
Blaye Hospital
Blaye, 33390, France
Bordeaux University Hospital
Bordeaux, 33000, France
Charles Perrens Hospital
Bordeaux, 33000, France
Cadillac Hospital
Cadillac, 33410, France
Sud-Gironde Hospital
Langon, 33210, France
Libourne Hospital
Libourne, France
Sainte Foy la Grande Hospital
Sainte-Foy-la-Grande, 33220, France
Study Officials
- PRINCIPAL INVESTIGATOR
Frantz THIESSARD, MD, PhD
University Hospital, Bordeaux
Central Study Contacts
Frantz THIESSARD, MD, PhD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2022
First Posted
June 15, 2022
Study Start
January 2, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
June 15, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share